Latest NewsCadila Healthcare receives USFDA nod for Deferasirox tabletsadminJuly 9, 2018 July 9, 2018 Cadila Healthcare has received approval from the US health regulator, for Deferasirox tablets for oral suspension in the strengths of 125 mg, 250 mg and 500...